medicalxpress - Hundreds of thousands of people diagnosed with cancer are still alive today but were never genetically tested, either because testing was not available or was not routinely offered at the time of their diagnosis. These patients are just as likely as those…
AI Summary: A national study has been launched to assess whether genetic testing can refine follow-up care for cancer survivors, tailoring surveillance to individual risk and potentially reducing unnecessary tests. The large-scale effort seeks to integrate genomic data into survivorship plans to better predict late effects and allocate resources to those most likely to benefit.
Prosigna-guided OPTIMA trial shows chemo can be safely skipped in many ER+/HER2− breast cancers / 25 hrs
Liquid biopsy blood test promises personalized lung cancer detection and monitoring / 4 days
UCLA unveils low-cost blood test to detect multiple cancers from one sample / 7 wks
Bowelbabe Fund reaches £20M and announces vaccine initiative / 1 month
UK records highest-ever skin cancer cases; severe cases rise / 9 days
Introducing ISCO 2026 chairs and program highlights / 5 wks
ESMO–EURACAN issues updated uveal melanoma guideline / 1 month
StackHealth RSS

StackHealth Time Machine
NorthFeed Inc. Terms and Conditions / Privacy Policy
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.